Artemis Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$133M |
| 2 |
Merck
MRK
|
+$101M |
| 3 |
Ferguson
FERG
|
+$74M |
| 4 |
Gartner
IT
|
+$69.6M |
| 5 |
Burlington
BURL
|
+$61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$188M |
| 2 |
Elevance Health
ELV
|
+$93.2M |
| 3 |
Bio-Rad Laboratories Class A
BIO
|
+$81.3M |
| 4 |
IQVIA
IQV
|
+$79.3M |
| 5 |
PG&E
PCG
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.74% |
| 2 | Industrials | 15.89% |
| 3 | Healthcare | 15.35% |
| 4 | Financials | 12.14% |
| 5 | Consumer Staples | 9.55% |
Similar funds
Artemis Investment Management's Q4 2022 Portfolio in Review
As of Q4 2022, Artemis Investment Management held 267 positions worth $8.82B, up 0.6% from $8.77B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Artemis Investment Management withdrew a net $637M in Q4 2022, closing 45 positions and reducing 109 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $81.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Artemis Investment Management opened a new position in Ferguson worth $81M.
- Artemis Investment Management's largest Q4 2022 buy was Ferguson: 635,157 shares worth $81M.
- Artemis Investment Management added most to Wells Fargo in Q4 2022, an estimated $133M increase.
- Artemis Investment Management's biggest Q4 2022 reduction was Coca-Cola, cutting an estimated $188M.
- Artemis Investment Management fully exited Bio-Rad Laboratories Class A in Q4 2022, selling an estimated $81.3M.
- Artemis Investment Management's ten largest holdings make up 22% of its $8.82B portfolio in Q4 2022.
- Artemis Investment Management opened 40 new positions and closed 45 in Q4 2022.
- Artemis Investment Management's portfolio value rose 0.6% quarter-over-quarter to $8.82B.
Based on Artemis Investment Management's 13F filing for Q4 2022, filed 25 Jan 2023.